Live Breaking News & Updates on Inhalation Aerosol
Stay updated with breaking news from Inhalation aerosol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A latest study published by Future Market Insights (FMI) uncovers factors propelling the demand in the nasal antihistamines market. It offers analysis of scope for expansion in various segments ....
Covis Pharma Group COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced today top-line results from a 400 patient phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ciclesonide metered-dose inhaler in non-hospitalized patients 12 years of age and older with symptomatic COVID-19 infection. ....
(0) ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) Covis Pharma Group (the Company ), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced today top-line results from a 400 patient phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ciclesonide metered-dose inhaler in non-hospitalized patients 12 years of age and older with symptomatic COVID-19 infection. The primary endpoint of the study was time to alleviation of COVID-19-related symptoms of cough, dyspnea, chills, feeling feverish, repeated shaking with chills, muscle pain, headache, sore throat, and new loss of taste or smell, defined as symptom-free for a continuous period of = 24 hours by Day 30. A sub-group analysis showed that time to alleviation of cough was the most improved symptom in the ciclesonide arm compared to the placebo arm by 6 days in 75% ....
News | March 17, 2021 Sandoz In-Licenses Brand And Authorized Generic Of Respiratory Medicine Proventil® HFA (Albuterol Sulfate) Inhalation Aerosol From Kindeva Drug Delivery, With Immediate Generic Availability In US Source: Kindeva Drug Delivery Albuterol sulfate is used to treat or prevent bronchospasm in patients four years and older with reversible obstructive airway disease, such as asthma, and to prevent exercise-induced bronchospasm 1 Immediate launch of our authorized generic will help ensure a reliable supply of albuterol medicines, as respiratory products see increased demand over past year Deal allows Sandoz to further grow respiratory portfolio and availability of our authorized generic ensures patients have access to an important medicine at an affordable price ....
Share this article Share this article PRINCETON, N.J., March 16, 2021 /PRNewswire/ Sandoz Inc. today announced the in-licensing of commercial distribution rights to the brand and authorized generic of respiratory inhalation medicine Proventil ® HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, a global contract development and manufacturing organization supplying the product. Our albuterol sulfate authorized generic is immediately available to patients in the US. There has been a surge in demand for albuterol medicines over the past year. Hospitals increasingly switched to using metered-dose albuterol inhalers rather than nebulizers to treat the growing number of COVID-19 patients. Pharmacies also saw increased demand for albuterol inhalers after the CDC recommended that Americans stock up on necessary medications. ....